What Does LNR Mean in an Ampullary Cancer Pathology Report?

If your pathology report after surgery for ampullary cancer mentions a Lymph Node Ratio (LNR), it describes the proportion of lymph nodes containing cancer cells compared to the total number of lymph nodes the pathologist examined ^[1][2]. LNR is a supplemental prognostic marker that can help your oncology team better estimate your risk of recurrence ^[3][2]. However, it is just one piece of the puzzle—it does not replace standard staging and is not a standalone rule for determining your treatment.

How is the Lymph Node Ratio Calculated?

During surgery to remove the tumor (such as a Whipple procedure), the surgeon removes surrounding tissue that includes lymph nodes. In the lab, a pathologist then finds and examines these nodes under a microscope.

The LNR is calculated using the numbers found in your pathology report:

$LNR = \frac{\text{Number of Positive Nodes}}{\text{Total Number of Nodes Examined}}$

• Number of positive nodes: The number of lymph nodes where the pathologist found cancer cells.
• Total number of nodes examined: The total number of regional lymph nodes the pathologist identified and tested.

Why the total number matters:
The total number of nodes examined (the bottom number of the equation) heavily influences your ratio.

• Example 1: If 1 node is positive out of 20 examined, your LNR is 1/20, or 5% (0.05).
• Example 2: If 1 node is positive out of only 5 examined, your LNR is 1/5, or 20% (0.20).

Because a smaller number of examined nodes can make the ratio mathematically unstable or artificially high, doctors look at both the ratio and the raw numbers ^[4].

What Your LNR Can—and Cannot—Tell You

LNR is considered a prognostic factor (information linked to a likely outcome), not a predictive factor (evidence that a specific treatment will work) ^[3][5].

• What it can tell you: In observational studies, a higher LNR has been associated with a higher risk of recurrence, as it suggests a greater concentration of cancer in the sampled lymphatic system ^[2][1]. In some studies of ampullary cancer, examining a higher number of nodes (such as 17 or more) was associated with more accurate staging and better survival, though this threshold varies by study and is not a universal clinical standard ^[4]. A lower count does not automatically mean the surgery was inadequate.
• What it cannot tell you: There is no universally accepted “high” or “low” LNR cutoff for ampullary cancer ^[2]. It does not give you an individual percentage risk of recurrence, and a low LNR does not guarantee the cancer will not return. It also does not replace your official AJCC N stage (which categorizes the absolute number of positive nodes).

How LNR Fits Into Chemotherapy Decisions

After surgery, your multidisciplinary team will discuss whether you should receive adjuvant chemotherapy. This is treatment given after surgery to reduce the chance of recurrence by targeting possible microscopic disease. It is not a guarantee that recurrence will be prevented, and it may be recommended even if your nodes are negative.

There is no single standardized adjuvant chemotherapy regimen for all ampullary cancer patients ^[6][7]. A higher LNR (along with positive nodes) may support a discussion about the potential benefits of adjuvant chemotherapy ^[8][5][9]. However, LNR alone does not predict whether chemotherapy will be helpful or dictate which specific drugs to use.

The Bigger Picture: Your Complete Pathology Report

Treatment decisions are based on a complete view of your health, your recovery from a major operation, and several other pathology factors:

• T Stage (Tumor depth): How deeply the tumor grew into the ampulla or surrounding tissues ^[10].
• N Stage: The standard staging category based on whether nodes are positive, regardless of the ratio ^[11].
• Margin Status: Whether the outer edges of the removed tissue are clear of cancer cells (R0) or contain cancer cells (R1) ^[10].
• Histologic Subtype: Whether the cells look more like intestinal cells or pancreatobiliary cells under a microscope. Pancreatobiliary types are sometimes associated with a higher risk, which may influence discussions about systemic therapy ^[12].
• Other Features: Factors like tumor grade (how abnormal the cells look), or lymphovascular/perineural invasion (whether cancer cells are seen invading blood vessels, lymph vessels, or nerves).

Reviewing pathology results can be frightening, but remember that LNR is just one clue among many. Your care team will evaluate all these factors together to create a personalized follow-up plan.